United Kingdom· GB-APID-35790811000001105
Aimovig 70mg/1ml solution for injection pre-filled pens
A erenumab product containing erenumab, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Erenumab is registered in 13 of 19 countries.
Countries holding a registration under ATC N02CD01 (erenumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Erenumab · ATC N02CD01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Erenumab
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N02CD01
- ATC class
- Erenumab
- Defined daily dose
- 2.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7613421015114
- gtin7613421041076
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erenumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAIMOVIGNovartis Europharm Limited, Dublin
- BelgiumAimovig 70 mgNovartis Europharm
- IcelandAimovigNovartis Europharm Limited*
- SwedenAimovig 70 mg Injektionsvätska, lösning i förfylld injektionspennaNovartis Europharm Limited
- SpainAIMOVIG 70 MG SOLUCION INYECTABLE EN PLUMA PRECARGADANovartis Europharm Limited
- IrelandAimovig 70 mg Solution for injectionNovartis Europharm Limited
- United StatesAIMOVIGAmgen, Inc
- FinlandAimovigParanova Oy
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aimovig
- Liechtenstein · Aimovig
- Norway · Aimovig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/35f16e7f-952d-4030-a3de-5724b601cf9b GET /v1/drugs/35f16e7f-952d-4030-a3de-5724b601cf9b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "35790811000001105",
"desc": "Aimovig 70mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd)",
"form": "Solution for injection",
"vpid": "35813011000001106",
"source": "dmd",
"vtm_id": "775810006",
"strength": "70 mg",
"substance": "Erenumab",
"ingredient": "Erenumab",
"supplier_code": "2920101000001102"
}See everything about erenumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.